Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Non-Current Deffered Revenue (2018)

Historic Non-Current Deffered Revenue for International Stem Cell (ISCO) over the last 1 years, with Q4 2018 value amounting to $182000.0.

  • International Stem Cell's Non-Current Deffered Revenue changed N/A to $182000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $182000.0, marking a year-over-year change of. This contributed to the annual value of $182000.0 for FY2018, which is N/A changed from last year.
  • Per International Stem Cell's latest filing, its Non-Current Deffered Revenue stood at $182000.0 for Q4 2018.
  • International Stem Cell's 5-year Non-Current Deffered Revenue high stood at $182000.0 for Q4 2018, and its period low was $182000.0 during Q4 2018.